The tumour suppressor PTEN, also named MMAC1 or TEP1, is associated with a number of malignancies in human populations. This protein has a dual protein phosphatase activity, being also capable to dephosphorylate phosphatidylinositol 3,4,5 triphosphate. We have studied the mechanism of growth suppression attributable to PTEN. We observed that PTEN overexpression inhibits cell growth in a variety of normal and transformed, human and murine cells. Bromodeoxyuridine (BrdU) incorporation and TUNEL labelling experiments in transiently transfected cells demonstrate that this inhibition is due to a cell cycle arrest rather than induction of apoptosis. Given that PTEN is unable to cause cell growth arrest in retinoblastoma (Rb) de®cient cell lines, we have explored the possible requirement for pRb in the PTEN-induced inhibition of cell proliferation. We found that the co-expression of SV40 antigen, but not a mutant form (which binds exclusively to p53), and cyclin D1/cdk4 are able to overcome the PTEN-mediated growth suppression. In addition, the reintroduction of a functional pRb, but not its relatives p107 or p130, in Rb-de®cient cells restores the sensitivity to PTEN-induced arrest. Finally, the hyperphosphorylation of transfected pRb is inhibited by PTEN co-expression and restored by PI-3K co-expression. Accordingly, PTEN gene is mostly expressed, in parallel to Akt, in mid-late G 1 phase during cell cycle progression prior to pRb hyperphosphorylation. Finally, we have studied the signal transduction pathways modulated by PTEN expression. We found that PTEN-induced growth arrest can be rescued by the coexpression of active PI-3K and downstream eectors such as Akt or PDK1, and also certain small GTPases such as Rac1 and Cdc42, but not by active Ha-ras, raf or RhoA. Collectively, our data link the tumour suppressor activities of PTEN to the machinery controlling cell cycle through the modulation of signalling molecules whose ®nal target is the functional inactivation of the retinoblastoma gene product.
Keywords: PTEN/MMAC1/TEP1; cell cycle; retinoblastoma protein; signal transduction Mutations or deletions of the PTEN gene have been identi®ed in a large fraction of prostate, brain, breast, endometrial, skin and kidney tumours, thus placing PTEN among the most commonly mutated genes in human cancer Steck et al., 1997) . The mechanism responsible for these tumour suppressor activities, either by inducing apoptosis, modifying the dierentiation state of the cells, or inhibiting cell proliferation, as yet has not been well established. To study these aspects, we cloned PTEN cDNA into the expression vector pcDNA3.1 (Invitrogen) under the control of the cytomegalovirus promoter, and monitored the ability of PTEN to inhibit cell growth by colony formation assays in a series of human and murine transformed and non-transformed cell lines. We observed that compared to empty vector, the overexpression of PTEN led to a decrease in the number of colonies in all non-transformed cells (HaCaT human keratinocytes, MCA3D murine keratinocytes and NIH3T3 murine ®broblasts (Figure 1a) . Similarly, we also found growth inhibition in Ki-ras transformed 3T3 ®broblasts and in Haca4, C57B1 and CarcB transformed murine keratinocytes (characterized by bearing mutated Ha-ras alleles and lacking the correspondent wt alleles, C57B1 and CarcB, or transformed by the infection with a Ha-ras coding retrovirus, Haca4). Finally, we did not observe such eect of PTEN overexpression in v-src transformed 3T3 murine ®broblasts, nor in C33A or Saos2 human tumour cell lines. Several authors have recently shown that PTEN overexpression inhibits cell growth in cell lines bearing mutations in their endogenous PTEN gene (Furnari et al., 1997; Li and Sun, 1998) . We have therefore studied the expression of the endogenous PTEN gene in all the above mentioned cell lines by Northern analysis (Figure 1b) . Although we cannot discard the presence of point mutations, we found proper PTEN expression in all of them except C33A line, which in turn, does not display growth inhibition by PTEN overexpression. Thus, in disagreement with others (Furnari et al., 1997; Li and Sun, 1998) , our data indicate that the overexpression of PTEN seems to be unable to cause the cell growth arrest in cells lacking endogenous gene expression. On the other hand, the fact that PTEN can inhibit cell growth in both Ki-ras transformed 3T3, and in murine keratinocyte cell lines representing the ®nal stages of murine skin carcinogenesis, indicates that PTEN suppressor functions can be dominant with respect to ras oncogenic transformation, and suggests that this protein is acting downstream of ras signalling, in disagreement with the results obtained by others showing that PTEN inhibits ras activation . Two mechanisms have been described as potentially responsible for the growth suppression induced by PTEN. On the one hand, the data obtained in mice lacking PTEN gene and the adenovirus-driven overexpression of PTEN in cell lines, have indicated that PTEN expression may induce apoptosis (Di Cristofano et al., 1998; Suzuki et al., 1998; Stambolic et al., 1998; . On the other hand, it has also been shown that PTEN may induce cell cycle arrest in several cell lines (Furnari et al., 1997 (Furnari et al., , 1998 Li and Sun, 1998) . To test if any of these mechanisms is responsible for the observed cell growth arrest, we subcloned PTEN into the bicistronic pIRES EGFP vector (Clontech) and analysed, upon transient transfection into sensitive and non-sensitive cells, the spontaneous induction of apoptosis or, alternatively, the ability to enter S phase displayed by the transfected (GFP-positive) and non-transfected cells (GFP-negative). We found that in cells sensitive to PTEN-induced cell growth arrest (see Figure 1a) , there is a clear inhibition of BrdU incorporation, while in v-src transformed ®broblasts, which are not sensitive, there is no such inhibition (Figure 2a) . Conversely, we did not observe any eect of PTEN expression in the spontaneous induction of apoptosis, neither in sensitive nor non-sensitive cells when measured by TUNEL analysis (Figure 2b ). Although we cannot discard that Figure 1 (a) Exogenous PTEN expression inhibits cell growth in dierent human and murine transformed and non-transformed cell lines. PTEN cDNA was ampli®ed by RT ± PCR using primers 5'-GACATGACAGCCATCATCAA-3' and 5'-AATTCA-GACTTTTGTAATTTGTGTATG-3' and the PCR product was cloned into pcDNA3.1 vector under the CMV promoter. The integrity of the construct was monitored by DNA sequencing. The listed cell lines were transfected with pCMVPTEN or with empty cDNA3.1 vector. Forty-eight hours after transfection plates were cultured in the presence of Zeocin (to which resistance is provided in the vector, 2 ± 3 weeks later colonies were ®xed and stained, and the number of colonies was referred to that obtained in the same experiments using empty vector. Experiments were done in duplicate and repeated at least once. Data are shown as mean+s.d. (b) Expression of endogenous PTEN gene in the dierent cell lines. Total RNA was extracted from cultures and probed by Northern analysis for PTEN cDNA. Note that all the cell lines but C33A express PTEN (the dierent transcripts are described in Furnari et al. (1997) ). The RNA loading was controlled by hybridization of the same blot against ribosomal 7S probe Figure 2 PTEN expression induces cell cycle arrest but not apoptosis. PTEN cDNA was subcloned into the bicistronic pIRES vector (Clontech), which also codes for GFP expression, and transiently transfected into the quoted cell lines growing onto glass coverslips. (a) Forty-eight hours after transfection BrdU (10 mM) was added to the cultures for a further 5 h. At this time, cells were ®xed in 4% paraformaldehyde in PBS for 10 min at 48C and processed for immuno¯uorescence using a monoclonal antibody against BrdU (Boehringer Mannheim) according to the manufacturer's recommendations. The number of BrdU positive cells in GFP expressing and non-expressing cells was determined. Note that, in cells sensitive to PTEN-induced growth arrest (as determined in Figure 1a ), there is a clear decrease in the rate of BrdU incorporation, indicative of S phase entry inhibition. (b) In parallel experiments to those shown in (a), but in the absence of BrdU incubation, the rate of apoptosis was determined for GFP positive and negative cells using TUNEL cell death kit (Boehringer Mannheim) according to the manufacturer's recommendations. Note that the apoptotic rate is similar both in GFPpositive and -negative cells, suggesting that PTEN expression does not induce, in the absence of exogenous treatments, an increase in apoptosis. Data in (a) and (b) come from four independent experiments scoring at least 150 cells on each experiment and are shown as mean+s.d.
the BrdU incorporation inhibition could correspond to alternative mechanisms, such as G2 arrest or the inhibition of DNA synthesis enzymes, these results indicate, in agreement with the mechanism reported in glioblastoma cells (Furnari et al., 1997 (Furnari et al., , 1998 Li and Sun, 1998) , that the observed cell growth arrest is due to the inhibition of cell cycle progression at the G 1 to S phase transition rather than apoptosis induction. However, this does not preclude the possibility that the presence or absence of PTEN protein could in fact modulate apoptosis, in particular when this process is induced by exogenous treatments, as reported in the case of PTEN gene-de®cient cells (DiCristofano et al., 1998; Stambolic et al., 1998) .
The inhibition of S phase entry indicates that PTEN expression can aect the machinery controlling cell cycle progression. The main mechanisms controlling cell cycle progression during G 1 are mediated by p53 and/or the retinoblastoma family of proteins (pRb, p107 and p130) (reviewed in Picksley and Lane, 1994; Weinberg, 1995) . Moreover, the absence of PTENinduced growth-arrest in pRb-de®cient (Schener et al., 1991; Lukas et al., 1994) human tumour cells Saos 2 and C33A (Figure 1a) suggests the involvement of the pRb pathway. To con®rm this aspect, we studied if the reintroduction of a functional pRb could restore the cell sensitivity to PTEN-induced growth arrest. To this, C33A cells were co-transfected with either pRb, p107 or p130 along with PTEN or empty vector and the number of colonies was scored in each case. It is worth mentioning that, in C33A cells pRb expression is unable to cause cell cycle arrest (93+10.5% colonies with respect to empty vector, see also Paramio et al. (1999) ; Zhu et al. (1993 Zhu et al. ( , 1995 ). We observed that the (Paramio et al., 1998; . The number of colonies were scored as in Figure 1a and related to those obtained with empty vector together with the corresponding pocket protein coding plasmids. (b) Reversion of the growth arrest induced by PTEN expression in colony formation assays performed in HaCaT cells by the co-expression of wt T Ag, which binds and inactivates p53 and pRb and its relatives, but not a mutant form (k 1 TAg), which only binds and inactivates p53. (c) In HaCaT cells, the co-expression of either CycD1 or cdk4 partially abolishes the inhibition induced by PTEN and the co-expression of both Cyclin D1 and cdk4 completely abolishes such inhibition. (d) PTEN expression inhibits the phosphorylation of a transfected pRb in C33A. Cells were transfected in p60 petri dishes with 5 mg of the quoted constructs together with 1 mg of CMVbGal (the total DNA was kept to 20 mg by adding pcDNA3). Forty-eight hours after transfection protein extracts were obtained and probed by Western blotting against bGal to normalize transfection eciency (see Paramio et al., 1998) or against total or hypophosphorylated pRb using speci®c mouse monoclonal antibodies (Pharmingen, upper panel) . The expression of cyclin D1 protein was also monitored using a rabbit polyclonal antibody (Santa Cruz Biotech.). Note that transfected pRb is eciently phosphorylated in absence of PTEN and induces cyclin D1 expression. On the contrary, PTEN reduces pRb phosphorylation and abolishes cyclin D1 expression, although this eect is reversed by the co-expression of the activated catalytic subunit of PI-3K, p110 CAAX, and the presence of wortmannin (100 nM) leads to a reduced phosphorylation of pRb and cyclin D1 expression in the presence of both PTEN and p110 CAAX. Experiments in a, b and c were done in duplicate and repeated at least once. Data are shown as mean+s.d. expression of pRb, but not that of p130 or p107, restored the ability of PTEN to inhibit cell proliferation in these cells (Figure 3a) .
The involvement of the pRb pathway was further con®rmed by two independent approaches. First, HaCaT cells were co-transfected with PTEN and either a wild type SV40 large T antigen, which binds and inactivates both p53 and pRb, or a mutant form of this protein (k 1 T Ag), which binds to and inactivates p53 but not pRb or its relatives. We observed that co-expression of the wild type T Ag, but not of the mutant k 1 T Ag form, reversed PTENinduced arrest, suggesting that pRb (or its relatives), but not p53, is involved in the inhibition of cell growth induced by PTEN (Figure 3b ). This is consistent with the fact that HaCaT cells bear mutations in both alleles of the p53 gene which render the protein transcriptionally inactive, but are sensitive to PTEN-induced inhibition of cell cycle progression. Secondly, since pRb is functionally inactivated by hyperphosphorylation through the activity of dierent complexes of cyclins and cyclindependent kinases during normal cell cycle progression (Weinberg, 1995; Geng and Weinberg, 1993; Hinds et al., 1992) , we studied whether co-expression of combinations of these molecules in addition to PTEN could reverse the inhibitory functions observed. We found that, compared to control transfections containing the corresponding cyclins and/or cdks plus empty vector, co-expression of cyclin D1 or cdk4 partially rescued PTEN-induced arrest, whilst the co-expression of both Cyc D1 and Cdk4 completely alleviates the PTEN inhibitory eect. Given that the main in vivo and in vitro substrate for cycD1/cdk4 complexes is the pRb protein (see Weinberg, 1995) , these data also support the functional involvement of Rb gene product in the PTEN-induced cell growth arrest.
Finally, and most signi®cantly, to con®rm that PTEN expression can modulate pRb phosphorylation, C33A cells were transfected with PTEN, pRb or both constructs and the expression of pRb was monitored by Western blotting (Figure 3d ). We observed that transfected pRb is eciently phosphorylated in C33A, in parallel with an induction of cyclin D1 protein, in agreement with our previous results (Paramio et al., 1999) , whilst the co-expression of PTEN inhibits this hyperphosphorylation and reduces the cyclin D1 protein expression (Figure 3d ). Given that PTEN may dephosphorylate phosphatidylinositol 3,4,5 triphosphate (Maehama and Dixon, 1998), thus inhibiting the PI-3 kinase signalling cascade (Li and Sun, 1998; Stambolic et al., 1998; Furnari et al., 1998; Haas-Kogan et al., 1998; Wu et al., 1998) , and the fact that PI-3K can modulate pRb phosphorylation (Prennan et al., 1997; Klippel et al., 1998) , we also analysed if the co-expression of a catalitically active subunit of PI-3K (p110CAAX, kindly provided by Dr J Downward, ICRF, London) could restore the hyperphosphorylation of pRb. We found that, in these transfections (PTEN+pRb+p110CAAX) the level of pRb phosphorylation and cyclin D1 expression are similar to those observed when pRb is transfected alone (Figure 3d ). Moreover, in these triple transfections, the treatment of the cells with the PI-3K inhibitor wortmannin, inhibits pRb phosphorylation (Geng and Weinberg, 1993; Fahraeus et al., 1996; Paramio et al., 1998) . After 3 days cells were allowed to re-enter the cell cycle by addition of 10% FBS and, at the quoted times total RNA was obtained and probed by Northern (a) against PTEN, Akt or the p110 subunit of PI-3K using the corresponding full length cDNAs. A ribosomal 7S probe was used to normalize the RNA loading. (b) In parallel experiments protein extracts obtained at the quoted times after serum re-stimulation were probed by Western blotting against pRb using IF8 monoclonal antibody (Fahraeus et al., 1996; Paramio et al., 1998 neat supernatant kindly provided by Dr DP Lane, Dundee, UK)
Figure 5 PTEN-induced growth arrest is speci®cally rescued by the co-expression of certain activated signalling molecules. NIH3T3 (open bars) or HaCaT keratinocytes (closed bars) were co-transfected with 10 mg PTEN or empty vector (pcDNA3.1) along with 10 mg of plasmid coding for the dierent stated activated molecules. Colonies were selected by incubating the transfected cells with the optimal dose of Zeocin (Invitrogen) for 2 ± 4 weeks. The colonies were then ®xed, stained with giemsa and counted. The number of colonies obtained using PTEN plus the corresponding plasmid was then referred to that obtained using empty vector plus the same plasmid. Experiments were done in triplicate and repeated twice. Data are shown as mean+s.d. and reduces cyclin D1 expression (Figure 3d) . Collectively, these results indicate that PTEN overexpression inhibits the cell cycle progression through the Retinoblastoma tumour suppressor gene product, and this process seems to be mediated by the ability of PTEN to inhibit the PI-3K signalling pathway.
The observed S phase entry inhibition induced by PTEN overexpression in a pRb-dependent manner suggests that endogenous PTEN may also function during the G 1 phase of the cell cycle. We therefore analysed the PTEN gene expression pattern during cell cycle progression. To this, HaCaT cells were synchronized in G 0 by serum starvation and allowed entry into G 1 and S phase by serum re-stimulation (Geng and Weinberg, 1993; Fahraeus et al., 1996; Paramio et al., 1998) . At dierent times, extracts were obtained and analysed for PTEN expression by Northern blot (Figure 4a ). We found that PTEN expression is high in cells in G 0 (Figure 4a , lane denoted 0 h), decreasing very fast after serum re-stimulation, and increasing during mid-late G 1 (6 ± 12 h). Interestingly, the pRb phosphorylation as analysed by Western botting (Figure 4b ), is clearly preceded by such increased expression of PTEN. Afterwards, PTEN expression decreased (18 ± 27 h). Given the reported interrelationship between PTEN and Akt expression , the same blot was re-probed against Akt cDNA. We found that the Akt expression pattern is very similar to that displayed by PTEN gene (Figure  4a ), although the decrease observed after mid late G 1 is less pronounced than that of PTEN. Finally, given that PI-3K signalling appears to mediate the functional interrelation between PTEN and Akt, we also analysed the expression of the catalitic subunit of PI-3K (p110) during the cell cycle progression. The results demonstrate no major alterations of p110 expression ( Figure  4a ), suggesting that, as expected, the increase in PI-3K activity during cell cycle is regulated by signalling mechanisms independent of PI-3K gene expression (Roche et al., 1994) .
The functions of PTEN as a tumour suppressor appear to be related to its activities as: (i) a dual protein phosphatase (Myers et al., 1997) promoting the inhibition of the focal adhesion kinase (FAK) and the signalling downstream of this molecule Tamura et al., 1998) , and (ii) its ability to dephosphorylate phosphatidylinositol 3,4,5 triphosphate (Maehama and Dixon, 1998) ; thus inhibiting the PI-3K signalling cascade (Li and Sun, 1998; Stambolic et al., 1998; Furnari et al., 1998; Haas-Kogan et al., 1998; Wu et al., 1998) . These two pathways converge to modulate speci®c cell processes, in particular the organization of the actin cytoskeleton, in which the eects of PTEN expression have been recently well established , and also the modulation of the cell cycle progression. Given the observed ability of PTEN overexpression to promote cell cycle arrest, we have studied the involvement of these signalling pathways in the process. We have carried out rescue experiments in NIH3T3 and HaCaT cells co-transfecting PTEN with plasmids coding for activated forms of dierent signalling molecules. We found ( Figure 5 ) that activated Ha-ras or v-raf (kindly provided by Dr J Moscat, CBM, Madrid, Spain) do not alleviate the PTEN-induced cell growth arrest, in agreement with out data obtained in Ki-ras transformed ®broblasts or in transformed murine keratinocytes (Figure 1a) . Given that these constructs have been shown to eciently induce MAPK/MEK cascades, at least in 3T3 cells (Cai et al., 1997; Berra et al., 1995) , these results suggest that the ras/raf/MAPK mitogenic signals are not sucient to alleviate PTEN eects, or alternatively, that PTEN acts also downstream of raf in this cascade. In this regard, it has been shown that activated MEK1 can overcome some PTEN induced eects .
Members of the Rho family of GTPases can regulate the organisation of the actin cytoskeleton at dierent levels. In fact, Rho controls the actin stress ®bers and focal adhesion complexes, Rac regulates the lamellipodia production and membrane rues, and Cdc42 stimulates the formation of ®lopodia. Given that PTEN expression is also involved in the reorganization of actin cytoskeleton inhibiting cell migration and spreading , it is conceivable that a functional link between PTEN and Rho family of GTPases may exist. On the other hand, these proteins also regulate cell cycle progression through G 1 (Olson et al., 1995) . To study if PTEN expression modulates signalling through this family of proteins, we performed similar rescue experiments using activated forms of RhoA, Rac1 or Cdc42Hs (all of them in the pcDNA3 vector, kindly provided by Dr JC Lacal, IIB, Madrid, Spain). We found that, despite being expressed from the same CMV promoter, Rac1 and Cdc42Hs, but not Rho A, can eciently alleviate PTEN-induced growth arrest ( Figure 5 ), suggesting that these members of the Rho family of GTPases may in¯uence cell cycle progression by dierent pathways. In agreement with this hypothesis, it has been shown that Rac1 and Cdc42Hs, but not RhoA, activate the JNK/SAPK pathway (Chou and Blenis, 1996) , whilst Rho A modulates the induction of the cyclin-dependent kinase inhibitor p21 Waf1/Cip1 , which occurs in parallel to ras/raf activation (Olson et al., 1998) .
We next investigated the involvement of PI-3K signalling in the PTEN-induced cell growth arrest. We found that the co-expression of either a membrane targeted catalytic subunit of PI-3K, (p110CAAX) or Akt (both kindly provided by Dr J Downward, ICRF, London, UK) or phosphoinositide 3 phosphatedependent kinase, PDK1 (kindly provided by Dr K Anderson, Babraham Inst. Cambridge, UK) eciently rescued the PTEN-induced inhibition of cell proliferation ( Figure 5 ). These results are in agreement with those indicating that PTEN induced cell death can be eciently rescued by Akt co-expression , and also with the increased Akt activity found in glioblastoma cells as a consequence of PTEN mutations (Haas-Kogan et al., 1998) . On the other hand, they are at variance with those reported by who found that PTEN-induced inhibition of FAK-and integrin-dependent signalling pathways does not aect Akt activation. Our data also are at variance with the recently reported ability of PTEN to inhibit gene expression (Wu et al., 1998) , since this activity can be repressed by Akt but not by PI-3K. Moreover these last authors did not ®nd any defect on cell cycle progression or apoptosis induction upon PTEN transfection (Wu et al., 1998) .
Our results indicate that PTEN-induced cell cycle arrest is mediated mainly by inhibiting PI-3K-dependent signal transduction pathways. In addition we have observed that activated Rac1 and Cdc42 can rescue the PTEN-induced growth arrest. These molecules bind and activate PI-3K (Zheng et al., 1994; Tolias et al., 1995) thus modulating cell invasiveness and motility (Keely et al., 1997) . Therefore, this PI-3K activation could also account for the observed rescue. However, since activated Ha-ras can also bind and activate PI-3K (Rodriguez-Viciana et al., 1996) and is unable to overcome the PTEN-induced inhibition (Figure 5 ), this suggests that the Rac-1 or Cdc42-dependent activation of PI-3K is not the main mechanism responsible for the observed eect. The activation of PI-3K triggers multiple signals characteristic of growth factor action, leading to cell cycle entry (Klippel et al., 1998) . These include the stimulation of p70 S6 kinase, Akt and JNK activities (Klippel et al., 1996) . Among these signals, the JNK/SAPK and Akt pathways are activated by Cdc42 and Rac1, although in a PI-3K-dependent manner (Zheng et al., 1994) , therefore suggesting that they are not the eectors of the rescue. On the other hand, the p70 S6K pathway, which is required for cell cycle progression during G 1 (Pearson and Thomas, 1995) and is also stimulated by Akt (Burgering and Coer, 1995) and PDK1 (Alessi et al., 1997) , can be stimulated by activated forms of Cdc42 and Rac1, but not RhoA (Chou and Blenis, 1996) . Interestingly, the p70 S6K pathway appears to control the cyclin D1 mRNA levels and protein stability, and its inhibition by rapamycin treatment leads to the inhibition of G1 to S transition and impaired phosphorylation of pRb (Hashelmosseini et al., 1998; Takuwa et al., 1999) .
Collectively, we show here that PTEN overexpression leads to a cell cycle arrest in dierent cell types in a retinoblastoma-dependent manner, irrespective to the state of the endogenous PTEN gene, and these activities appear to be mediated by the speci®c inhibition of the PI-3K signalling pathway. However, further work will be required to ascertain which of the possible signal transduction pathways, depending on PI-3K is the actual target of PTEN and how they may be linked to cell cycle machinery to promote the pRbdependent cell cycle arrest.
